|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vascular depression for radiology: A review of the construct,methodology,and diagnosis显示文摘Vascular depression(VD)as defined by magnetic resonance imaging(MRI)has been proposed as a unique subtype of late-life depression.The VD hypothesis posits that cerebrovascular disease,as characterized by the presence of MRIdefined white matter hyperintensities,contributes to and increases the risk for depression in older adults.VD is also accompanied by cognitive impairment and poor antidepressant treatment response.The VD diagnosis relies on MRI findings and yet this clinical entity is largely unfamiliar to neuroradiologists and is rarely,if ever,discussed in radiology journals.The primary purpose of this review is to introduce the MRI-defined VD construct to the neuroradiology community.Case reports are highlighted in order to illustrate the profile of VD in terms of radiological,clinical,and neuropsychological findings.A secondary purpose is to elucidate and elaborate on the measurement of cerebrovascular disease through visual rating scales and semi-and fully-automated volumetric methods.These methods are crucial for determining whether lesion burden or lesion severity is the dominant pathological contributor to VD.Additionally,these rating methods have implications for the growing field of computer assisted diagnosis.Since VD has been found to have a profile that is distinct from other types of late-life depression,neuroradiologists,in conjunction with psychiatrists and psychologists,should consider VD in diagnosis and treatment planning. | Sara N Rushia Al Amira Safa Shehab Jeffrey N Motter Dakota A Egglefield Sophie Schiff Joel R Sneed Ernst Garcon | 2020 | World Journal of Radiology2020，12，5： | 5 |
| 2 | Recent clinical experience with vaccines using MPL-and QS-21-containing adjuvant systems显示文摘 | Garcon N Van Mechelen M | | Expert Rev Vaccines0，0，4： | 1 |
| 3 | Stability of soybean recombinant plastome over six generations显示文摘 | Dufourmantel N Tissot G Garcon F | 2006 | Transgenic Res2006，15，3： | 1 |
| 4 | Glaxo Smith Kline adjuvant systems in vaccines: concepts, achievements and perspectives显示文摘 | Garcon N Chomez P Van Mechelen M | 2007 | Expert Rev Vaccine2007，6，5： | 1 |
| 5 | Recent clinical experience with vaccines using MPL-and QS-21-containing adjuvant systems显示文摘 | GARCON N VAN MECHELEN M | | 0，，04： | 1 |
| 6 | Stability of soybean recombinant plastome over six generations 显示文摘 | Dufourmantel N Tissot G Garcon F | 2006 | Transgenic Res2006，153，： | 1 |
| 7 | Generation and analysis of soybean plastid transformants expressing Bacillus thuringiensts/erylAb protoxin显示文摘 | DUFOURMANTEL N TISSOT G GOUTORBE F GARCON F MUHR C JANSENS S PELISSIER B PELTIER G DUBALD M | 2005 | Plant Molecular Biology2005，58，5： | 1 |
| 8 | The safety evaluation of adjuvants during vaccine development: the AS04 experience 显示文摘 | Garcon N Segal L Tavares F | 2011 | Vaccine2011，29，27： | 1 |
| 9 | GlaxoSmithK Line Adjuvant Systems in Vaccines:Concepts,Achievements and Perspectives显示文摘 | Garcon N Chomez P Van M M | 2007 | Expert Rev Vaccines2007，6，5： | 1 |
| 10 | GlaxoSmithKline adjuvant systems in vaccines:concepts,achievements and perspectives显示文摘 | Garcon N Chomez P van Mechelen M | 2007 | Expert Rev Vaccines2007，6，5： | 1 |
| 11 | The safety evalua- tion of adjuvants during vaccine development: the AS04 experi- ence显示文摘 | GARCON N SEGAL L TAVARES F | 2011 | Vaccine2011，29，27： | 1 |
| 12 | GlaxoSmithKline adju?vant systems in vaccines: Concepts, achievements and perspec?tives 显示文摘 | Garcon N Chomez P Van Mechelen M | 2007 | Expert Rev Vaccines2007，6，5： | 1 |
| 13 | Adjuvant Systemsin vaccines: concepts,acievements and perspectives 显示文摘 | GARCON N CHOMEZ P VAN MECHELEN M | 2007 | ExpertRev Vaccines2007，6，5： | 1 |
| 14 | Recent clinical experience with vac- cines using MPL- and QS-21-containing adjuvant systems 显示文摘 | Garcon N Van Mechelen M | 2011 | Expert Rev Vaccines2011，10，4： | 1 |
| 15 | Development of RTS, S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant显示文摘 | Garcon N Heppner D G Cohen J | 2003 | Expert Rev Vaccines2003，2，2： | 1 |
| 16 | Development and evaluation of AS03, an adjuvant system containing a-toco- pherol and squalene in an oil-in-water emulsion 显示文摘 | Garcon N Vaughn DW Didierlaurent AM | 2012 | Expert Rev Vaccines2012，11，3： | 1 |
| 17 | Generation of fertile transplastomic soybean显示文摘 | Dufourmantel N Pelissier B Garcon F | 2004 | Plant Molecular Biology2004，55，： | 1 |
| 18 | The safety evaluation of adjuvants during vaccine develop- ment: the AS04 experience显示文摘 | Garcon N Segal L Tavares F Van Mechelen M | 2011 | Vaccine2011，29，27： | 1 |
| 19 | Recent clinical experience with vaccines using MPL- and QS-Zl-containing adju- vant systems显示文摘 | Garcon N Van Mechelen M | 2011 | Expert Rev Vaccines2011，10，4： | 1 |
| 20 | The safety evaluation of ad- juvants during vaccine development: The AS04 experience 显示文摘 | Garcon N Segal L Tavares F | 2011 | Vaccine2011，29，27： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员